Guidelines for chronic obstructive pulmonary disease
- 12 August 2004
- Vol. 329 (7462) , 361-363
- https://doi.org/10.1136/bmj.329.7462.361
Abstract
Footnotes Competing interests WMcN has been reimbursed by Glaxo-SmithKline, and Boehringer-Ingelheim for attending several conferences. He has been paid for speaking at medical conferences organised by GlaxoSmithKline, AstraZeneca, Boehringer-Ingelheim, and Zambon. He has received funding for research from Pfizer, GlaxosmithKline, and SMB Pharmaceuticals but not directly related to any of the drugs discussed in the article.Keywords
This publication has 7 references indexed in Scilit:
- The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2004
- Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.2004
- Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary diseaseEuropean Respiratory Journal, 2003
- Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 updateEuropean Respiratory Journal, 2003
- Systemic Effects of Chronic Obstructive Pulmonary DiseasePublished by Wiley ,2000
- Domiciliary Oxygen Therapy Services: Clinical Guidelines and Advice for Prescribers2000
- BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.1997